我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
3
0 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
已完成
2
66.7%
终止
1
33.3%
暂无批准数据
- The global ENT devices market was valued at USD 24.89 billion in 2025 and is projected to reach USD 44.91 billion by 2035, growing at a CAGR of 6.08%. - Hearing aids remain the largest product segment at approximately 32.40% share, while surgical ENT devices are the fastest-growing at roughly 6.52% CAGR. - North America held the largest regional share at approximately 37.60% in 2025, with Asia-Pacific emerging as the fastest-growing region at about 6.59% CAGR. - FDA over-the-counter hearing aid reform is expected to make an estimated 28 to 38 million Americans with untreated mild-to-moderate hearing loss newly reachable through consumer channels.